Author:
Low K. Brooks,Ittensohn Martina,Le Trung,Platt James,Sodi Stefano,Amoss Max,Ash Olivia,Carmichael Ellen,Chakraborty Ashok,Fischer Jessica,Lin Stanley L.,Luo Xiang,Miller Samuel I.,Zheng Li-mou,King Ivan,Pawelek John M.,Bermudes* David
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference33 articles.
1. Pawelek, J., Low, K.B., and Bermudes, D. 1997. Tumor-targeted Salmonella as a novel anti-cancer vector. Cancer Res. 57: 4537–4544.
2. Bone, R.C. 1992. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). J. Am. Med. Assoc. 268: 3452–3455.
3. Dinarello, C.A., Gelfand, J.A., and Wolff, S.M. 1993. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. J. Am. Med. Assoc. 269: 1829–1835.
4. Flad, H.-D., Loppnow, H., Rietschel, E.T., and Ulmer, A.J. 1993. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187: 303– 316.
5. Kovach, N.L., Yee, E., Munford, R.S., Raetz, C.R.H., and Harlan, J.M. 1990. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J. Exp. Med. 172: 77–84.
Cited by
407 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献